Tirzepatide runs for the full cycle
Wegovy (semaglutide) is a prescription medicine licensed by the MHRA for chronic weight management in adults with obesity or overweight with weight-related comorbidities
Payers are redefining their PBM approach for 2025
When acute illness occurs in PA, propionic acid accumulates leading to biochemical features including profound metabolic acidosis (due to ketone body production and organic acid accumulation), hypoglycemia, and hyperammonemia (see figure below)
This is especially for people dealing with conditions like IBS, leaky gut, food intolerances, or autoimmune flare-ups
For the obesity group, 361 people were prescribed semaglutide and 20 people developed the condition, a seven times higher rate